Description
Gliclazide (Melanov) MR 60mg Tablets (30’s)
Gliclazide (Melanov) MR 60mg is a modified-release oral antidiabetic medication from the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. It helps control blood glucose levels by stimulating insulin secretion in a sustained manner.
Key Features:
-
Modified-release formulation provides prolonged and steady blood sugar control.
-
Stimulates pancreatic beta cells to release insulin.
-
Suitable for once-daily dosing, improving patient compliance.
-
Can be used alone or with other antidiabetic agents such as metformin.
-
Supports effective glycemic control and reduces diabetes complications.
Indications:
-
Treatment of type 2 diabetes mellitus when diet and exercise alone are insufficient.
-
Appropriate as monotherapy or combination therapy.
Dosage & Administration:
-
Usually taken once daily with breakfast or the first main meal.
-
Dose tailored according to patient’s blood glucose response.
-
Regular blood glucose monitoring is recommended.
Precautions:
-
Not suitable for type 1 diabetes or diabetic ketoacidosis.
-
Use cautiously in patients with hepatic or renal impairment.
-
Educate patients on symptoms and management of hypoglycemia.
-
Inform healthcare professionals about other concurrent medications.
Possible Side Effects:
-
Hypoglycemia (low blood sugar)
-
Weight gain
-
Gastrointestinal discomfort (nausea, indigestion)
-
Rare allergic reactions
Storage:
-
Store in a cool, dry place below 30°C.
-
Keep out of reach of children.
Reviews
There are no reviews yet.